Introduction The unprecedented success of chimeric antigen receptor (CAR)-T-cell therapy
in the management of B-cell malignancies comes with a price of specific side effects …

Background Chimeric antigen receptor (CAR)‐T‐cell therapies have revolutionized the
management of acute lymphoblastic leukemia, non‐Hodgkin lymphoma, and multiple …

Background: Plasma-derived medicinal products (PDMPs) are medicinal products derived
from human plasma, and a number of PDMPs are listed on the WHO Model List of Essential …

Plasma, the noncellular component of blood, contains many proteins important for
homeostasis. Deficiencies in plasma components can contribute to the pathogenesis of …

At the symposium organized by the International Plasma and Fractionation Association and
European Blood Alliance, experts presented their views and experiences showing that the …

This review is focused on the use of hyperimmune globulin therapy to treat some infectious
diseases of viral or bacterial origin. Despite the introduction of antibiotics and vaccines …

Background: The large-scale utilization of immunoglobulins in patients with inborn errors of
immunity (IEIs) since 1952 prompted the discovery of their key role at high doses as …

Abstract Background and Objectives: Although plasmapheresis is generally considered
safe, there are still concerns about the long-term effects of plasma donation on …

Background The demand and consumption of immunoglobulins (IgGs) are growing, and
there are many difficulties in obtaining supplies. The aim of the study was to analyze the …

Background Immunoglobulin (IG) therapy is widely used to treat primary and secondary
immune deficiencies and as immunomodulatory agent for various disorders. There is great …